Fig. 6. POU2F2 promotes aerobic glycolysis via PDPK1-dependent activation of PI3K/AKT/mTOR pathway.
A Immunoblotting of POU2F2, PDPK1, AKT, p-AKT, mTOR, and p-MTOR in shCtrl, shPOU2F2, and shPOU2F2/PDPK1 cells with or without NSC156529 treatment (20 μM). B Glucose uptake in GBM cells with different treatment. C Glucose consumption in GBM cells with different treatment. D Glycolytic flux changes in GBM cells with different treatment. E Lactate production in GBM cells with different treatment. F Lactate dehydrogenase activity in GBM cells with different treatment. G Immunoblotting of GLUT1, HK2, and PKM2 in shCtrl, shPOU2F2, and shPOU2F2/PDPK1 cells with or without NSC156529 treatment. All data were shown as the mean ± SD, **p < 0.01.